OPEN END TURBO PUT WARRANT - ASTRAZENECA ADR | Market Closed - Boerse Frankfurt Warrants 12:17:58 2024-07-03 EDT | ||
| 1.48 EUR | +1.37% |
|
| Current month | +10.45% | ||
| 1 month | +18.40% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
More news
| Date | Price | Change |
|---|---|---|
| 24-07-03 | 1.48 | +1.37% |
| 24-07-02 | 1.46 | +5.80% |
| 24-07-01 | 1.38 | +2.99% |
| 24-06-28 | 1.34 | 0.00% |
| 24-06-27 | 1.34 | +8.06% |
Real-time Boerse Frankfurt Warrants
Last update July 03, 2024 at 12:17 pm
More quotesStatic data
| Product type | Knock-Out sin Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ASTRAZENECA PLC |
| Issuer | UBS |
| WKN | UM5S8E |
| ISIN | DE000UM5S8E7 |
| Date issued | 2024-05-14 |
| Strike | 91.97 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.38 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.54 € |
|---|---|
| Lowest since issue | 1.07 € |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
153.4
USD
Average target price
174.6
USD
Spread / Average Target
+13.78%
- Stock Market
- Certificates
- Certificat
